
“Opponents of legalizing cannabis for medicinal purposes are fond of arguing that the plant must be subjected to the same standards of clinical study and FDA review as conventional medicines. According to a just-published analysis of some 200 newly FDA-approved medications, few conventional drugs are tested in multiple, large-scale clinical assessing safety and efficacy trials prior to market approval. By comparison, there exists over 20,000 published studies or reviews in the scientific literature referencing the cannabis plant and its cannabinoids, nearly half of which were published within the last five years.”
http://www.hightimes.com/read/cannabis-has-been-studied-more-many-fda-approved-pharmaceuticals
Related posts:
Bitcoin: A Buy, or Bypass?
Obama approved F-16 fighter jets as gift to Egypt
Justin Raimondo: The Mossad Caucus Exposed
Great is the Guilt of an Unnecessary War - Vietnam Edition
NYPD a ‘quasi-military organization,’ according to outgoing Ray Kelly
Caitlin Long: Vulnerability of Fed’s Balance Sheet
Homeland Security Raids Homes Seizing Vehicles For EPA Violations
Are You a Milk Cow for the Government?
Oracle security chief to customers: Stop checking our code for vulnerabilities
Customs & Border Protection Logged Eight-Fold Increase in Drone Surveillance for Other Agencies
Can We Call Syrian Rebels Terrorists Now?
Italian Business Taxpayers Feel 'Persecuted'
Will the End of Cannabis Prohibition Benefit the Small Farmer?
Pakistan bans BlackBerry messaging, e-mail for “security reasons”
Obama 'Hope' poster artist says drones have killed hope